⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4408924 | 1.00 | — | — | |
| SCHEMBL22456915 | 0.73 | — | — | |
| SCHEMBL26998880 | 0.71 | — | — | |
| SCHEMBL19053458 | 0.71 | — | — | |
| SCHEMBL22051380 | 0.71 | — | — | |
| SCHEMBL30238124 | 0.71 | — | — | |
| SCHEMBL8548244 | 0.69 | — | — | |
| SCHEMBL23042931 | 0.67 | — | — | |
| SCHEMBL27391601 | 0.67 | — | — | |
| SCHEMBL21800791 | 0.67 | TP53 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376524-B1 | DERIVATIVES OF CYCLOSPORIN A | CYPRALIS LTD (GB) | 2017-03-15 | — | — | EP | disclosed |
| EP-2280989-B1 | CYCLOSPORIN ANALOGS AND THEIR USE IN THE TREATMENT OF HCV INFECTIONS | SCYNEXIS INC (US) | 2016-02-10 | — | — | EP | disclosed |
| US-9090671-B2 | Macrocyclic peptides | SCYNEXIS, INC. (US) | 2015-07-28 | — | — | US | disclosed |
| US-8536114-B2 | Macrocycles | SCYNEXIS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| EP-2376524-A1 | DERIVATIVES OF CYCLOSPORIN A | Scynexis, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| EP-2280989-A2 | CYCLOSPORIN ANALOGS AND THEIR USE IN THE TREATMENT OF HCV INFECTIONS | Scynexis, Inc. (US) | 2011-02-09 | — | — | EP | disclosed |
| WO-2010076329-A1 | DERIVATIVES OF CYCLOSPORIN A | SCYNEXIS, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100173836-A1 | NOVEL MACROCYCLES | CYPRALIS LIMITED (GB) | 2010-07-08 | — | — | US | disclosed |
| WO-2010002428-A2 | NOVEL MACROCYCLIC PEPTIDES | SCYNEXIS, INC. (US) | 2010-01-07 | — | — | WO | disclosed |
| US-20090312300-A1 | NOVEL MACROCYCLIC PEPTIDES | CYPRALIS LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |